DJ Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Wednesday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Corbus Pharmaceuticals Holdings Inc. $(CRBP)$ slipped 1.14% to $7.82 Wednesday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ Composite Index rising 0.07% to 26,674.73 and the Dow Jones Industrial Average rising 0.36% to 50,644.28.
This was the stock's third consecutive day of losses.
Corbus Pharmaceuticals Holdings Inc. closed 61.96% below its 52-week high of $20.56, which the company achieved on October 20th.
The stock underperformed when compared to some of its competitors Wednesday, as Vanda Pharmaceuticals Inc. $(VNDA)$ rose 3.86% to $6.46, Fortress Biotech Inc. (FBIO) rose 2.60% to $2.76, and Viking Therapeutics Inc. (VKTX) rose 2.79% to $31.66.
Trading volume (2.1 M) eclipsed its 50-day average volume of 344,802.
Data source: Dow Jones Market Data, FactSet. Data compiled May 27, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
May 27, 2026 17:20 ET (21:20 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
Comments